Life Sciences in Focus: Portfolio Support
LSX Investor Perception Survey 2019

In this extract from the LSX Investor Perception Survey 2019, we focus on the ways in which investor respondents assist portfolio company development outside of the financing they provide, as well as examining their preferred level of involvement with investees. The 3rd annual LSX Investor Perception Survey tracks sentiment, aims, and preferences among the life science investment community. It has been designed to identify developing investment trends, to enable life sciences companies to better understand investors' priorities and areas of focus, and to allow investors to benchmark their approach against those of peers. 

Download the white paper to:

  • Discover the support mechanisms respondents offer to investee companies.
  • Learn how hands on investors like to be with their portfolio companies.
  • Read commentary and insights from Stephan Christgau, Senior Partner at Novo Seeds.

Enter your details here to receive the white paper

Formerly Known as Blog Resize

LSX (formerly Biotech and Money) is an influential community of senior life science decision makers. Through our impactful events, powerful thought leadership content and unique networking opportunities, we exist to forge a fundamentally better way to promote and facilitate investment, financing, partnerships and deal making in healthcare.